Loading…
High levels of PD-L1 on platelets of NSCLC patients contributes to the pharmacological activity of Atezolizumab
Colarusso, Chiara, Falanga, Anna, Terlizzi, Michela, De Rosa, Ilaria, Somma, Pasquale, Sommella, Eduardo Maria, Caponigro, Vichy, Panico, Luigi, Salviati, Emanuela, Campiglia, Pietro, Salatiello, Giuseppe, Tramontano, Teresa, Maiolino, Piera, Pinto, Aldo, Sorrentino, Rosalinda
Published in Biomedicine & pharmacotherapy (01.12.2023)
Published in Biomedicine & pharmacotherapy (01.12.2023)
Get full text
Journal Article
Loading…
Loading…
Comprehensive analysis of TROP2, PD-L1, stromal (s)TILs, and HER2 expression patterns in patients (pts) with metastatic HR+HER2- breast cancer
Heiling, Hillary, Hughes, Melissa E., Binboğa Kurt, Busem, DiLullo, Molly, Li, Tianyu, Tayob, Nabihah, Curigliano, Giuseppe, Mittendorf, Elizabeth A., Lin, Nancy U., Tolaney, Sara M., Garrido-Castro, Ana Christina
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Loading…
Loading…
Loading…
PD-L1-R: A MR based surrogate for PD-L1 expression in Glioblastoma multiforme
Sforazzini, Francesco, Salome, Patrick, Kudak, Andreas, Ulrich, Matthias, König, Laila, Warta, Rolf, Bougatf, Nina, Debus, Juergen, Herold-Mende, Christel, Knoll, Maximilian, Abdollahi, Amir
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Loading…
Loading…
3789 SERUM AND URINARY SOLUBLE PD-1, PD-L1 AND PD-L2 AS BIOMARKERS FOR CHECKPOINT INHIBITOR RELATED ACUTE INTERSTITIAL NEPHRITIS
Gomez-Preciado, Francisco, Valenzuela, Laura Martinez, Pampols, Paula Anton, Gomez-Tena, Marina, Goma, Montserrat, Lertora, Ana Melissa Rau, Rodríguez, Belén Rubio, Nadal, Ernest, Jove, Maria, Oliveras, Xavier Fulladosa, Cruzado, Josep, Ambros, Joan Torras, Draibe, Juliana
Published in Nephrology, dialysis, transplantation (14.06.2023)
Published in Nephrology, dialysis, transplantation (14.06.2023)
Get full text
Journal Article
Loading…
Cardiac adverse events of PD-1 and PD-L1 inhibitors in cancer protocol for a systematic review and network meta-analysis: A protocol for systematic review
Han, Deting, Dong, Jianyong, Li, Honglin, Ma, Tao, Yu, Wenjun, Song, Lucheng
Published in Medicine (Baltimore) (01.01.2020)
Published in Medicine (Baltimore) (01.01.2020)
Get full text
Journal Article
Loading…
Loading…
PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity
Ferrata, Martina, Schad, Arno, Zimmer, Stefanie, Musholt, Thomas J., Bahr, Katharina, Kuenzel, Julian, Becker, Sven, Springer, Erik, Roth, Wilfried, Weber, Matthias M., Fottner, Christian
Published in Frontiers in oncology (2019)
Published in Frontiers in oncology (2019)
Get full text
Journal Article
Loading…
Assessment of programmed death ligand 1 (PD-L1) expression in cervical intraepithelial neoplasia and carcinoma cervix
Shelly, Divya, Sharma, Pragya, Mishra, P.S., Mulajker, Deepak, Bisht, Niharika, Mukundan, Hari, Kumar, Shiv
Published in Medical journal. Armed Forces India (01.07.2025)
Published in Medical journal. Armed Forces India (01.07.2025)
Get full text
Journal Article
Loading…
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study
Kurosaki, Takashi, Chamoto, Kenji, Suzuki, Shinichiro, Kanemura, Hiroaki, Mitani, Seiichiro, Tanaka, Kaoru, Kawakami, Hisato, Kishimoto, Yo, Haku, Yasuharu, Ito, Katsuhiro, Sato, Toshiyuki, Suminaka, Chihiro, Yamaki, Mami, Chiba, Yasutaka, Yaguchi, Tomonori, Omori, Koichi, Kobayashi, Takashi, Nakagawa, Kazuhiko, Honjo, Tasuku, Hayashi, Hidetoshi
Published in Frontiers in immunology (11.12.2023)
Published in Frontiers in immunology (11.12.2023)
Get full text
Journal Article
Loading…
Loading…
The cardiac-related adverse events of PD-1/PD-L1 immunotherapy in advanced or metastatic lung cancer: a RCT-based meta-analysis
Chen, Bangsheng, Xu, Anyi, He, Yujing, Zhang, Yueming, Cheng, Dongying, Fang, Yingying, Ruan, Jiale, Dai, Min, Wang, Yu, Zhang, Jie
Published in Supportive care in cancer (01.02.2024)
Published in Supportive care in cancer (01.02.2024)
Get full text
Journal Article
Loading…
A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease
Wu, Ching-Tse, Chu, Cheng-I, Wang, Feng-Yu, Yang, Hui-Yu, Tseng, Wei-Sung, Chang, Chuang-Rung, Chang, Chien-Chung
Published in Cell & bioscience (30.09.2022)
Published in Cell & bioscience (30.09.2022)
Get full text
Journal Article
Loading…
A first-in-human phase I study of FS118, an anti-LAG-3/PD-L1 bispecific antibody in patients with solid tumors that have progressed on prior PD-1/PD-L1 therapy
Yap, Timothy A, Papadopoulos, Kyriakos P., LoRusso, Patricia, Wong, Deborah J.L., Hu-Lieskovan, Siwen, Holz, Josefin-Beate
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Loading…
Phase I/IIa study of PM8001, a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with advanced tumors
Guo, Ye, Liu, Baogang, Lv, Dongqing, Cheng, Ying, Zhou, Tong, Zhong, Yahua, Hu, Changlu, Chen, Gang, Wu, Xiaohua, Yin, Yongmei, Wu, Lihua, Chen, Zhendong, Luo, Hong, Zhou, Xiaohong, Qin, Yanru, Yang, Yuxing, Luo, SuXia, Ma, Yanjie, Li, Yalin, Hu, Guoqiang
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Loading…
The current status and prospects of gut microbiota combined with PD-1/PD-L1 inhibitors in the treatment of colorectal cancer: a review
Deng, Min, Li, Xiaoyu, Wu, Huiming, Xue, Dingwen, Wang, Yize, Guo, Renkai, Cui, Yipeng, Jin, Chenfei, luo, Fei, Li, Huiyu
Published in BMC gastroenterology (16.05.2025)
Published in BMC gastroenterology (16.05.2025)
Get full text
Journal Article
Loading…
Does chemotherapy regimen matter for first-line immunochemotherapy in low programmed cell death ligand 1 (PD-L1)-expressing esophageal squamous cell carcinoma (ESCC)? A systemic review and meta-analysis
Lin, Pei-Shan, Shau, Wen-Yi, Shao, Yu-Yun, Chen, Chi-Ling, Hsu, Chih-Hung
Published in Journal of clinical oncology (01.02.2025)
Published in Journal of clinical oncology (01.02.2025)
Get full text
Journal Article